NYSE:BAX - Baxter International Stock Price, Forecast & News

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, November 19th. Investors of record on Friday, December 6th will be given a dividend of $0.22 per share on Thursday, January 2nd. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Thursday, December 5th. View Baxter International's Dividend History.

Baxter International announced that its Board of Directors has authorized a share buyback program on Tuesday, November 13th 2018, which authorizes the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 6.1% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's leadership believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) announced its quarterly earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 EPS for the quarter, topping the Zacks' consensus estimate of $0.74 by $0.06. The medical instruments supplier earned $2.77 billion during the quarter, compared to analyst estimates of $2.79 billion. Baxter International had a return on equity of 22.99% and a net margin of 13.80%. The firm's revenue was up 2.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.64 earnings per share. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for Baxter International.

15 analysts have issued 1-year price objectives for Baxter International's shares. Their forecasts range from $75.00 to $109.00. On average, they expect Baxter International's share price to reach $93.15 in the next year. This suggests a possible upside of 3.8% from the stock's current price. View Analyst Price Targets for Baxter International.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Media headlines about BAX stock have been trending very negative this week, InfoTrie reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Baxter International earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Baxter International.

Baxter International saw a decrease in short interest in the month of December. As of December 13th, there was short interest totalling 4,300,000 shares, a decrease of 18.4% from the November 28th total of 5,270,000 shares. Based on an average daily volume of 2,860,000 shares, the short-interest ratio is currently 1.5 days. Approximately 0.8% of the shares of the company are sold short. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR), Steris (STE) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Cisco Systems (CSCO), BlackRock (BLK), Johnson & Johnson (JNJ), Verizon Communications (VZ), Honeywell International (HON), Home Depot (HD), Alibaba Group (BABA), Procter & Gamble (PG) and Endologix (ELGX).

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (0.19%), Huntington National Bank (0.10%), PGGM Investments (0.09%), Gateway Investment Advisers LLC (0.06%), Nisa Investment Advisors LLC (0.05%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Meag Munich Ergo Kapitalanlagegesellschaft MBH, Bangor Savings Bank, United Services Automobile Association, Gateway Investment Advisers LLC, Calamos Advisors LLC, First Hawaiian Bank, Tocqueville Asset Management L.P. and Dalton Greiner Hartman Maher & Co.. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Nisa Investment Advisors LLC, FormulaFolio Investments LLC, Huntington National Bank, DNB Asset Management AS, Larson Financial Group LLC, Commerzbank Aktiengesellschaft FI and Baxter Bros Inc.. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $89.73.

Baxter International has a market capitalization of $45.81 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]